As we start the new year, LifeLink Ventures releases its 2022 Annual Biotech Report. We wish to connect private investors with emerging technologies that address global health challenges. To do so, first we must bring our investors closer to the biotech world.
Learn more about biotech trends, the technology supporting innovative therapeutics and our portfolio companies. To access the full document please click here: